REFERENCES
- Hess ML, Manson NH. Molecular oxygen: friend and foe. The role of oxygen free radical system in the calcium paradox, the oxygen paradox and ischaemia /reperfusion injury. J Mol. Cell Cardiol 1984; 16: 969–85.
- McCord JM. Free radicals and myocardial ischae-mia: overview and outlook. Free Radic Biol Med 1988; 4: 9–14.
- Ertl G, Kloner RA, Alexander RW, Braunwald E. Limitation of experimental infarct size by angio-tensin converting enzyme inhibitor. Circulation 1982; 65: 40–8.
- Lefer AM, Peck RC. Cardioprotective effects of captopril in acute myocardial ischaemia. Pharma-cology 1984; 29: 61–4.
- Hock CE, Ribeiro LGT, Lefer AM. Preserva-tion of ischemic myocardium by a new convert-ing enzyme inhibitor, enaprilic acid, in acute myocardial infarction. Am Heart J 1985; 109: 222–8.
- Van Gilst WH, De Graeff TA, Wesseling H, DeLangen CDJ. Reduction of reperfusion arryth-mias in the ischemic isolated rat heart by ACEIs: a comparison of captopril, enapril and HOE 498. J Cardiovasc Pharmacol 1986; 8: 722–8.
- Di Pasquale P, Paterna S, Valenza M, Valdes L, Albano V, Trombino G, et al. Effects of captopril on myocardial protection during cardioplegia. Int J Cardiol 1993; 42: 225–30.
- Uchiyama M, Mihara M. Determination of mal-ondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1977: 271–8.
- Burtis CA, Ashwood ER. Determination of lactate in whole blood. Tietz text book of clinical chemis-try. Philadelphia: Saunders, 1994: 976–8.
- Jong JW, Goldstein S. Changes in coronary venous inosine concentration and myocardial wall thick-ening during regional ischaemia in the pig. Circ Res 1974; 35: 111–16.
- Ellman GL. Tissue sulphydryl groups. Arch Bio-chem Biophys 1959; 82: 70–7.
- Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized GSH: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502–22.
- Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967; 69: 696–705.
- Braunwald E, Kloner RA. The stunned myocar-dium prolonged, post-ischemic ventricular dys-function. Circulation 1989; 66: 1146–9.
- Hearse DJ. Ischaemia, reperfusion, and the deter-minants of tissue injury. Cardiovasc Drugs Ther 1990; 4: 767–76.
- Ferrari R, Ceconi C, Curello S, Alfieri 0, Visioli 0. Myocardial damage during ischaemia and reperfu-sion. Eur Heart J 1993; 14 Suppl G: 25–30.
- Flitter WD. Free radicals and myocardial reperfu-sion injury. Br Med Bull 1993; 49: 545–55.
- Cohen MV. Free radicals in ischemic and reperfusion myocardial injury: Is this the time for clinical trials? Ann Intern Med 1989; 11: 918–31.
- Coretti MC, Koretsune Y, Kusuoka H, Chacko VP, Zweir JL, Marban E. Glycolytic inhibition and calcium overload as consequences of exogen-eously generated free radicals in rabbit heart. J Clin Invest 1991; 88: 1014–25.
- McMurray J, Chopra M. Influence of ACE inhibi-tors on free radicals and reperfusion injury: phar-macological curiosity or theraupetic hope. Br J Clin Pharmacol 1991; 31: 373–9.
- Westlin W, Mullane K. Does captopril attenuate reperfusion induced myocardial dysfunction by scavenging free radicals? Circulation 1988; 77 Suppl 1: 130–9.
- Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ven-tricle of the rat. Circ Res 1985; 57: 84–95.
- Di Napoli P, Di Gregorio G, Di Sanctis F, Gallina S, Di Girolama E. The myocardial protective effects of cardiac tissue ACE inhibition in experi-mental ischaemia-reperfusion in isolated rat heart. Cardioplegia 1993; 38: 107–12.
- Liu X, Engelman RM, Rousou JA, Cordis GA, Das DK. Attenuation of myocardial reperfusion injury by sulph-hydryl containing angiotensin con-verting enzyme inhibitors. Cardiovasc Drugs Ther 1992; 6: 437–43.
- Liu FM, Xu SC. Effect of captopril cardioplegia on renin-angiotensin system, prostaglandins, free radicals and electrolytes in the isolated hypother-mic ischemic and reperfusion rabbit heart. Chin Med J 1992; 106: 903–6.
- Johnston CI, Clappison BH, Anderson WP, Yasu-jima M. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol. 1982; 49: 1401–4.
- Koerner JA, Anderson BA, Dage RC. Protection against postischemic myocardial dysfunction in anesthetised rabbits with scavengers of oxygen derived free radicals : superoxide dismutase plus catalase, N-2 mercaptopropionyl glycine and captopril. J Cardiovasc Pharmacol 1991; 17: 185–91.
- Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Sur-vival after an experimental myocardial infarction: beneficial effects of long term therapy with capto-pril. Circulation 1985; 72: 402–12.
- Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Attenuation of progressive ventricu-lar enlargement following anterior MI in man by captopril. Circulation 1987; 76: 171.
- Prasad K, Kalra J, Bharadwaj B, Chaudhary AK. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocor-onary bypass surgery. Am Heart J 1992; 123: 37–45.
- Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982; 47: 412–26.
- Prasad K, Kalra J, Chan WP, Chaudhary AK. Effect of oxygen free radicals on cardiovascular functions at organ and cellular levels. Am Heart J 1989; 117: 1196–202.
- Jimenez E, del Nido P, Feinberg H, Levitsky S. Redistribution of myocardial calcium during ischaemia. Relationship to onset of contracture. J Thorac Cardiovasc Surg 1993; 105: 988–93.
- Menasche P, Grousset C, Peynet J, Mouas C, Bloch G, Piwnica A. Pretreatment with captopril improves myocardial recovery after cardioplegic arrest. J Cardiovasc Pharmacol 1992; 19: 402–7.
- Ceconi C, Curello S, Cargnoni A, Ferrari R, Albertini A, Visioli 0. The role of GSH status in the protection against ischaemia and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol 1988; 20: 5–13.
- Roth E, Török B, Zsoldos T, Maltkowics B. Lipid peroxidation and scavenger mechanism in experi-mentally induced heart infarcts. Basic Res Cardiol 1985; 80: 530–6.